Crystallization and preliminary X-ray diffraction studies of vitamin D3hydroxylase, a novel cytochrome P450 isolated fromPseudonocardia autotrophica
- 25 March 2009
- journal article
- crystallization communications
- Published by International Union of Crystallography (IUCr) in Acta Crystallographica Section F Structural Biology and Crystallization Communications
- Vol. 65 (4), 372-375
- https://doi.org/10.1107/s1744309109007829
Abstract
Vitamin D3 hydroxylase (Vdh) is a novel cytochrome P450 monooxygenase isolated from the actinomycete Pseudonocardia autotrophica and consisting of 403 amino-acid residues. Vdh catalyzes the activation of vitamin D3 via sequential hydroxylation reactions: these reactions involve the conversion of vitamin D3 (cholecalciferol or VD3) to 25-hydroxyvitamin D3 [25(OH)VD3] and the subsequent conversion of 25(OH)VD3 to 1,25-dihydroxyvitamin D3 [calciferol or 1,25(OH)2VD3]. Overexpression of recombinant Vdh was carried out using a Rhodococcus erythropolis expression system and the protein was subsequently purified and crystallized. Two different crystal forms were obtained by the hanging-drop vapour-diffusion method at 293 K using polyethylene glycol as a precipitant. The form I crystal belonged to the trigonal space group P31, with unit-cell parameters a = b = 61.7, c = 98.8 Å. There is one Vdh molecule in the asymmetric unit, with a solvent content of 47.6%. The form II crystal was grown in the presence of 25(OH)VD3 and belonged to the orthorhombic system P212121, with unit-cell parameters a = 63.4, b = 65.6 c = 102.2 Å. There is one Vdh molecule in the asymmetric unit, with a solvent content of 46.7%. Native data sets were collected to resolutions of 1.75 and 3.05 Å for form I and form II crystals, respectively, using synchrotron radiation. The structure solution was obtained by the molecular-replacement method and model refinement is in progress for the form I crystal.Keywords
This publication has 19 references indexed in Scilit:
- Structural insights from a P450 Carrier Protein complex reveal how specificity is achieved in the P450BioIACP complexProceedings of the National Academy of Sciences, 2008
- Structural Analysis of CYP2R1 in Complex with Vitamin D3Journal of Molecular Biology, 2008
- Characterization of LtsA from Rhodococcus erythropolis , an Enzyme with Glutamine Amidotransferase ActivityJournal of Bacteriology, 2005
- Conversion of vitamin D3 to 1α,25-dihydroxyvitamin D3 by Streptomyces griseolus cytochrome P450SU-1Biochemical and Biophysical Research Communications, 2004
- A novel system for expressing recombinant proteins over a wide temperature range from 4 to 35°CBiotechnology & Bioengineering, 2004
- Structure of cytochrome P450eryF involved in erythromycin biosynthesisNature Structural & Molecular Biology, 1995
- On the computation of the fast rotation functionActa Crystallographica Section D-Biological Crystallography, 1993
- Transformation of vitamin D3 to 1?,25-dihydroxyvitamin D3 via 25-hydroxyvitamin D3 using Amycolata sp. strainsApplied Microbiology and Biotechnology, 1992
- Solvent content of protein crystalsJournal of Molecular Biology, 1968
- CARBON MONOXIDE-BINDING PIGMENT OF LIVER MICROSOMES .I. EVIDENCE FOR ITS HEMOPROTEIN NATURE1964